{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:46:23Z","timestamp":1785681983265,"version":"3.56.0"},"reference-count":28,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Angioimmunoblastic T-cell lymphomas originate from T follicular helper cells and express respective markers (BCL6, CD10, CXCL13, ICOS, and PD-1). Although commonly present, bone marrow involvement by angioimmunoblastic T-cell lymphoma can be diagnostically challenging. Additionally, only little is known about the distribution of T follicular helper cells in healthy and reactively changed bone marrows or in samples affected by other lymphomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To establish a diagnostic approach to reliably identify bone marrow infiltration of angioimmunoblastic T-cell lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We analyzed the morphologic infiltration pattern and the expression of T follicular helper-cell markers in 42 matched paired lymph node and bone marrow samples and applied comparative clonality testing. Furthermore, we studied the expression of BCL6 and PD-1 in a control cohort of healthy, reactively changed, and otherwise affected bone marrows.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>We identified 3 different bone marrow infiltration patterns correlating with overall survival (interstitial\/micronodular infiltration with or without eosinophilia and diffuse infiltration with eosinophilia). The matched pairs showed a consistent (co)expression of PD-1 and BCL6 with a generally weaker expression in the bone marrow than in the lymph nodes. Comparative clonality testing was helpful in only a minority of cases. Infiltrates of the most important differential diagnoses contained either PD-1\u2013 or BCL6-positive tumor-infiltrating cells, but no coexpressing cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Bone marrow infiltration by angioimmunoblastic T-cell lymphoma displays 3 different patterns that correlate with prognosis. BCL6 and PD-1 can be reliably used to identify lymphoma infiltrates and to help rule out several differential diagnoses. Comparative clonality testing rarely provides additional value and cannot replace morphologic and phenotypic analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0007-oa","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T14:08:21Z","timestamp":1569506901000},"page":"602-611","source":"Crossref","is-referenced-by-count":9,"title":["Bone Marrow Infiltration of Angioimmunoblastic T-Cell Lymphoma: Identification and Prognostic Impact of Histologic Patterns and Diagnostic Application of Ancillary Phenotypic and Molecular Analyses"],"prefix":"10.5858","volume":"144","author":[{"given":"Magdalena M.","family":"Gerlach","sequence":"first","affiliation":[{"name":"From the Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Juskevicius","sequence":"additional","affiliation":[{"name":"From the Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visar","family":"Vela","sequence":"additional","affiliation":[{"name":"From the Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dirnhofer","sequence":"additional","affiliation":[{"name":"From the Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"From the Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"issue":"9","key":"2020081300291876000_i1543-2165-144-5-602-b01","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"2020081300291876000_i1543-2165-144-5-602-b02","first-page":"407","article-title":"Angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T follicular helper cell origin","author":"Dogan","year":"2017","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed"},{"issue":"1","key":"2020081300291876000_i1543-2165-144-5-602-b03","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00544634","article-title":"Hodgkin's disease with constantly high content of epithelioid cells [in German]","volume":"344","author":"Lennert","year":"1968","journal-title":"Virchows Arch A Pathol Pathol Anat"},{"issue":"7866","key":"2020081300291876000_i1543-2165-144-5-602-b04","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","article-title":"Angio-immunoblastic lymphadenopathy with dysproteinaemia","volume":"1","author":"Frizzera","year":"1974","journal-title":"Lancet"},{"issue":"1","key":"2020081300291876000_i1543-2165-144-5-602-b05","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197501022920101","article-title":"Immunoblastic lymphadenopathy: a hyperimmune entity resembling Hodgkin's disease","volume":"292","author":"Lukes","year":"1975","journal-title":"N Engl J Med"},{"issue":"2","key":"2020081300291876000_i1543-2165-144-5-602-b06","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(197802)41:2<578::AID-CNCR2820410226>3.0.CO;2-8","article-title":"Malignant lymphoma arising in angioimmunoblastic lymphadenopathy","volume":"41","author":"Nathwani","year":"1978","journal-title":"Cancer"},{"issue":"21","key":"2020081300291876000_i1543-2165-144-5-602-b07","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1055\/s-0028-1106350","article-title":"Immunoblastic adenopathy: clinical features, treatment and prognosis (author's transl) [in German]","volume":"100","author":"Radaszkiewicz","year":"1975","journal-title":"Dtsch Med Wochenschr"},{"issue":"8580","key":"2020081300291876000_i1543-2165-144-5-602-b08","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"2020081300291876000_i1543-2165-144-5-602-b09","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020081300291876000_i1543-2165-144-5-602-b10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"issue":"11","key":"2020081300291876000_i1543-2165-144-5-602-b11","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2020081300291876000_i1543-2165-144-5-602-b12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2020081300291876000_i1543-2165-144-5-602-b13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3324\/haematol.2009.010991","article-title":"The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation","volume":"95","author":"Marafioti","year":"2010","journal-title":"Haematologica"},{"issue":"7","key":"2020081300291876000_i1543-2165-144-5-602-b14","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.V80.7.1804.1804","article-title":"Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type","volume":"80","author":"Anagnostopoulos","year":"1992","journal-title":"Blood"},{"issue":"7","key":"2020081300291876000_i1543-2165-144-5-602-b15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"issue":"5","key":"2020081300291876000_i1543-2165-144-5-602-b16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1309\/AJCPQXKCHQH4VAJ5","article-title":"Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement","volume":"131","author":"Cho","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2020081300291876000_i1543-2165-144-5-602-b17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000478-200401000-00005","article-title":"CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma","volume":"28","author":"Attygalle","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081300291876000_i1543-2165-144-5-602-b18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-2141.2007.06577.x","article-title":"Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma","volume":"137","author":"Grogg","year":"2007","journal-title":"Br J Haematol"},{"issue":"1","key":"2020081300291876000_i1543-2165-144-5-602-b19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2009.06.016","article-title":"Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study","volume":"41","author":"Khokhar","year":"2010","journal-title":"Hum Pathol"},{"issue":"4","key":"2020081300291876000_i1543-2165-144-5-602-b20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/ijlh.12365","article-title":"ICSH guidelines for the standardization of bone marrow immunohistochemistry","volume":"37","author":"Torlakovic","year":"2015","journal-title":"Int J Lab Hematol"},{"issue":"12","key":"2020081300291876000_i1543-2165-144-5-602-b21","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/leu.2016.135","article-title":"Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis","volume":"30","author":"Juskevicius","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"2020081300291876000_i1543-2165-144-5-602-b22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"2020081300291876000_i1543-2165-144-5-602-b23","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1080\/10428194.2018.1459610","article-title":"Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study","volume":"59","author":"Hong","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2020081300291876000_i1543-2165-144-5-602-b24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/10428190701245138","article-title":"Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy","volume":"48","author":"Dunleavy","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2020081300291876000_i1543-2165-144-5-602-b25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ajh.21483","article-title":"The clonality of CD3+ CD10+ T cells in angioimmunoblastic T cell lymphoma, B cell lymphoma, and reactive lymphoid hyperplasia","volume":"84","author":"Zhang","year":"2009","journal-title":"Am J Hematol"},{"issue":"3","key":"2020081300291876000_i1543-2165-144-5-602-b26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2020081300291876000_i1543-2165-144-5-602-b27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/DAD.0b013e3182a72f8c","article-title":"Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma","volume":"36","author":"Park","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"2020081300291876000_i1543-2165-144-5-602-b28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/modpathol.2012.124","article-title":"Follicular center helper T-cell (TFH) marker positive mycosis fungoides\/Sezary syndrome","volume":"26","author":"Meyerson","year":"2013","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/5\/602\/2500723\/arpa_2019-0007-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/144\/5\/602\/2500723\/arpa_2019-0007-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:16Z","timestamp":1764790816000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/144\/5\/article-p602.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,9,26]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0007-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]}}}